Dr. Kazuya Uyesugi

DDS | Dentist



  
  974 Willow St, San Jose
  California, 95125-2344

  408-279-4337    408-279-4555 Maps & Directions
Dr. Kazuya Uyesugi is a San Jose, California based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 974 Willow St, San Jose. Patients can reach him at 408-279-4337.
Dr. Kazuya Uyesugi is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Kazuya Uyesugi speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Kazuya Uyesugi
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:974 Willow St, San Jose,
California, 95125-2344
Phone:408-279-4337
Fax:408-279-4555
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 6800100181
Enrollment ID: I20150730012016
NPI Number: 1255438354
NPI Enumeration Date: 20 Sep, 2006
NPI Last Update On: 04 Sep, 2013

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 974 Willow St,
San Jose, California
Zip: 95125-2344
Phone Number: 408-279-4337
Fax Number: 408-279-4555
Patients can reach Dr. Kazuya Uyesugi at 974 Willow St, San Jose, California or can call to book an appointment on 408-279-4337. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.

Comments/ Reviews: